FDMT
4D Molecular Therapeutics Inc.
$7.67
+$0.27(+3.65%)
91
Overall
--
Value
91
Tech
--
Quality
Market Cap
$312.44M
Volume
1.10M
52W Range
$2.24 - $11.77
Target Price
$28.78
EPS Estimates Overview
| Current Quarter | $-1.02 | Next Quarter | $-1.02 |
| Current Year | $-3.66 | Next Year | $-3.73 |
| QoQ Growth | +0.0% | YoY Growth | -1.9% |
| 3Y EPS CAGR | -5.1% | Target Price | $28.78 |
| Consensus | Buy | Upside | +275.2% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FDMT | $7.67 | +3.6% | 1.10M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get 4D Molecular Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW